type here...

CATEGORIES

Medication

LATEST

1234Page 3 of 4

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Surprising Link Between Probiotics, Anxiety, and Depression

Michael Hunter, MD -
MAJOR DEPRESSIVE DISORDER (MDD) IS A PREVALENT mental health condition. While clinicians commonly prescribe antidepressant medications for MDD, many do not experience full symptom relief.

Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction

Medika Life -
DANDRIDGE, Tenn. — Rachel Solomon and judges hadn’t been on the best of terms. Then Judge O. Duane Slone “dumbfounded” her. Solomon was given...

AI Presents Dangers That Hide With Incredible Ease

Pat Farrell PhD -
Artificial intelligence, aka AI, has become so advanced that it might be difficult to know whether you are speaking to a live person or...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories